Skip to main content
Equibles

Sandra A. Gardiner

CFO

Anebulo Pharmaceuticals, Inc. (ANEB)

Chief Accounting Officer

Anebulo Pharmaceuticals, Inc. (ANEB)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sandra A. Gardiner

Sandra A. Gardiner is recorded as CFO and Chief Accounting Officer at Anebulo Pharmaceuticals, Inc. (ANEB). Anebulo Pharmaceuticals, Inc. reported in an 8-K filed September 5, 2023 that Sandra A. Gardiner resigned as Acting Chief Financial Officer, effective September 28, 2023. Anebulo Pharmaceuticals, Inc. reported in an 8-K filed March 8, 2023 that Sandra A. Gardiner was appointed principal accounting officer, effective March 2, 2023. Anebulo Pharmaceuticals, Inc. reported in an 8-K filed March 8, 2023 that Sandra A. Gardiner was appointed Acting Chief Financial Officer, effective March 2, 2023.

“On August 29, 2023, in connection with the termination of the Master Services Agreement, Sandra A. Gardiner notified the Company of her resignation as the Company’s Acting Chief Financial Officer, including as the Company’s principal financial officer and principal accounting officer, effective as of the Termination Date.”
Anebulo Pharmaceuticals, Inc. Form 8-K, filed September 5, 2023 · Read the filing
“On March 2, 2023, the Company appointed Sandra A. Gardiner as the Company's Acting Chief Financial Officer, as well as the Company's principal financial officer and principal accounting officer, replacing Rex Merchant in such capacities.”
Anebulo Pharmaceuticals, Inc. Form 8-K, filed March 8, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Anebulo Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.